CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor

被引:20
|
作者
Ulgiati, D
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 12期
关键词
D O I
10.4049/jimmunol.167.12.6912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transcription of the human complement receptor type 2 (CR2/CD21) gene is controlled by both proximal promoter and intronic elements. CR2 is primarily expressed on B cells from the immature through mature cell stages. We have previously described the presence of an intronic element that is required for both cell- and stage-specific expression of CR2. In this study, we report the identification of a cell type-specific repressor element within the proximal promoter. This repressor sequence is shown by linker scanning mutagenesis to comprise an E box motif. By supershift analysis this element binds members of the basic helix-loop-helix family of proteins, in particular E2A gene products. Mutational analysis demonstrates that binding of E2A proteins is critical for functioning of this repressor. Thus, E2A activity is key not only for early B cell development, but also for controlling CR2 expression, a gene expressed only during later stages of ontogeny.
引用
收藏
页码:6912 / 6919
页数:8
相关论文
共 50 条
  • [21] Characterization of the CR2/CD21 proximal promoter: Functional role for AP1/AP2 sites and two adjacent Ebox motifs.
    Ulgiati, D
    Virasch, N
    Holers, VM
    FASEB JOURNAL, 2000, 14 (06): : A1035 - A1035
  • [22] An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene
    Makar, KW
    Pham, CTN
    Dehoff, MH
    O'Connor, SM
    Jacobi, SM
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 1998, 160 (03): : 1268 - 1278
  • [23] Follicular dendritic cells specifically express the long CR2/CD21 isoform
    Liu, YJ
    Xu, JC
    deBouteiller, O
    Parham, CL
    Grouard, G
    Djossou, O
    deSaintVis, B
    Lebecque, S
    Banchereau, J
    Moore, KW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01): : 165 - 170
  • [24] Reduced expression of the complement receptor type 2 (CR2, CD21) by synovial fluid B and T lymphocytes
    Illges, H
    Braun, M
    Peter, HH
    Melchers, I
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 122 (02): : 270 - 276
  • [25] Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain
    Hoefer, Melanie M.
    Aichem, Annette
    Knight, Andrew M.
    Illges, Harald
    MOLECULAR IMMUNOLOGY, 2008, 45 (08) : 2127 - 2137
  • [26] Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells
    Taylor, Rhonda L.
    Cruickshank, Mark N.
    Karimi, Mahdad
    Ng, Han Leng
    Quail, Elizabeth
    Kaufman, Kenneth M.
    Harley, John B.
    Abraham, Lawrence J.
    Tsao, Betty P.
    Boackle, Susan A.
    Ulgiati, Daniela
    CELLULAR & MOLECULAR IMMUNOLOGY, 2016, 13 (01) : 119 - 131
  • [27] Expression patterns of murine CR1 (CD35) and CR2 (CD21) within the B cell compartment.
    Takahashi, K
    Li, X
    Holers, M
    Waldschmidt, T
    FASEB JOURNAL, 1996, 10 (06): : 2666 - 2666
  • [28] Focused transcription from the human CR2/CD21 core promoter is regulated by synergistic activity of TATA and Initiator elements in mature B cells
    Rhonda L Taylor
    Mark N Cruickshank
    Mahdad Karimi
    Han Leng Ng
    Elizabeth Quail
    Kenneth M Kaufman
    John B Harley
    Lawrence J Abraham
    Betty P Tsao
    Susan A Boackle
    Daniela Ulgiati
    Cellular & Molecular Immunology, 2016, 13 : 119 - 131
  • [29] Changes in chromatin accessibility across the complement receptor 2 (CR2/CD21) gene promoter occurs during different stages of B cell development
    Cruikshank, Mark N.
    Fenwick, Emily J.
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 162 - 162
  • [30] EXPRESSION OF EPSTEIN-BARR-VIRUS NUCLEAR ANTIGEN-2 (EBNA2) INDUCES CD21/CR2 ON B-CELL AND T-CELL LINES AND SHEDDING OF SOLUBLE CD21
    LARCHER, C
    KEMPKES, B
    KREMMER, E
    PRODINGER, WM
    PAWLITA, M
    BORNKAMM, GW
    DIERICH, MP
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (06) : 1713 - 1719